Picture of Oxford Cannabinoid Technologies Holdings logo

OCTP Oxford Cannabinoid Technologies Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

RCS - GHS Capital Ltd - LETTER ON OXFORD CANNABINOID TECHNOLOGIES

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220310:nRSJ3798Ea&default-theme=true

RNS Number : 3798E  GHS Capital Ltd  10 March 2022

GHS CAPITAL PUBLISHES LETTER ON OXFORD CANNABINOID TECHNOLOGIES

 

London, UK, 10 March 2022: GHS Capital Limited, the holder of 8.14 per cent of
the issued ordinary share capital of Oxford Cannabinoid Technologies Holdings
plc (LSE: OCTP), publishes a letter sent to the Chair of the Board at OCTP on
9 March 2022.

 

The full text of the letter can be read here:
http://www.rns-pdf.londonstockexchange.com/rns/3798E_1-2022-3-10.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/3798E_1-2022-3-10.pdf)

 

Media enquiries:

Powerscourt Group

Sarah Macleod / Sam Austrums

+44 (0) 207 250 1446

GHS@powerscourt-group.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABDGDXUUBDGDG

Recent news on Oxford Cannabinoid Technologies Holdings

See all news